Apr. 2, 2020
Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT™, and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse and prevent the onset of diabetes. Nemaura is planning to submit a PMA application for sugarBEAT® during the second quarter of 2020 for FDA review of this device under medical device regulations. proBEAT™ comprises a non-invasive glucose monitor and a digital healthcare subscription service and is due to be launched in the US as a general wellness product. Visit NMRDinfo.com to learn more.
Bloomberg TV Show
CEO Interviews
"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."
1-800-REDCHIP (733-2447) | 431 E Horatio Ave, Suite #100, Maitland, FL 32751
"Discovering Tomorrow's Blue Chips Today." ® | Home | Contact | Privacy Policy | Disclosures
© 2024 RedChip Companies, Inc.